Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;50(1):128-39.
doi: 10.1016/j.bone.2011.09.053. Epub 2011 Oct 6.

Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases

Yuxin Li  1 , Christiaan Schiepers, Ralph Lake, Simin Dadparvar, Gholam R Berenji
Affiliations
Review

Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases

Yuxin Li et al. Bone. 2012 Jan.

Abstract

(18)F labeled sodium fluoride is a positron-emitting, bone seeking agent with more favorable skeletal kinetics than conventional phosphate and diphosphonate compounds. With the expanding clinical usage of PET/CT, there is renewed interest in using (18)F-fluoride PET/CT for imaging bone diseases. Growing evidence indicates that (18)F fluoride PET/CT offers increased sensitivity, specificity, and diagnostic accuracy in evaluating metastatic bone disease compared to (99m)Tc based bone scintigraphy. National Oncologic PET Registry (NOPR) has expanded coverage for (18)F sodium fluoride PET scans since February 2011 for the evaluation of osseous metastatic disease. In this article, we reviewed the pharmacological characteristics of sodium fluoride, as well as the clinical utility of PET/CT using (18)F-fluoride in both benign and malignant bone disorders.

PubMed Disclaimer

Publication types

MeSH terms